Skip to main content
. Author manuscript; available in PMC: 2014 Sep 16.
Published in final edited form as: Cochrane Database Syst Rev. 2011 May 11;(5):CD003911. doi: 10.1002/14651858.CD003911.pub2

Comparison 10.

Hypersensitivity

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Hypersensitivity: 3 vs 24 hour infusion 2 948 Risk Ratio (IV, Random, 95% CI) 1.86 [0.63, 5.52]
1.1 Breast cancer 1 557 Risk Ratio (IV, Random, 95% CI) 2.01 [0.51, 7.95]
1.2 Ovarian cancer 1 391 Risk Ratio (IV, Random, 95% CI) 1.64 [0.28, 9.69]